AVEO Oncology · 9 hours ago
Oncology Account Manager
Philadelphia, PA
Full-time
Onsite
Mid, Senior Level
5+ years expAVEO Oncology is a commercial-stage biopharmaceutical company focused on delivering medicines for cancer patients. They are seeking an Oncology Account Manager to promote FOTIVDA for renal cell carcinoma and manage territory sales performance while developing relationships with key customers.
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Hiring Manager
Chrissy Rynne
Responsibilities
The OAM will promote safe and effective use of FOTIVDA (tivozanib) within the labeled indication (RCC) and in accordance with company training and policies
Responsible for individual/territory sales performance and goal attainment
Understand the Oncology/RCC environment; have in-depth knowledge of disease-state, local drivers, treatment and referral patterns, etc
Develop strong relationships with key customers practicing in your geography
Prepare and implement a comprehensive business plan for territory
Exercise sound judgment and ensure integrity and compliance with company policies in all activities and communications
Foster AVEO core values and behaviors
Qualification
Required
BS in Business or Science; 5 - 10 years sales experience in pharmaceutical/biotechnology industry
Proven track record that demonstrates top sales accomplishments
Demonstrated ability to understand and communicate technical clinical material clearly and effectively
Ability to develop critical relationships with physicians, nurses and ancillary staff within academic hospitals, clinics, and private practice facilities
Possesses a strong work ethic, ability to develop priorities and manage time appropriately
Works with all members of a team effectively
Integrates innovative ideas in order to accomplish corporate and individual objectives
Ability to travel and valid driver's license in good standing required
Preferred
Demonstrated understanding of oncology therapeutic area, products and marketplace strongly preferred
Company
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$560.85MKey Investors
Hercules CapitalNew Enterprise AssociatesVenrock
2022-10-18Acquired
2021-03-22Post Ipo Equity· $55.2M
2020-08-10Post Ipo Debt· $35M
Leadership Team
Michael P. Bailey
President & Chief Executive Officer
Edgar Braendle
Chief Medical Officer
Recent News
New Enterprise Associates
2025-12-03
Company data provided by crunchbase